(Q37867126)

24 August 2017

1 reference

title

Advances in regional chemotherapy of the liver (English)

1 reference

24 August 2017

1 reference

Oliver Dudeck

1

1 reference

24 August 2017

Jens Ricke

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

21 April 2011

1 reference

Expert Opinion on Drug Delivery

24 August 2017

published in

1 reference

24 August 2017

volume

8

1 reference

24 August 2017

issue

8

1 reference

24 August 2017

page(s)

1057-1069

1 reference

Pharmacologic rationale for regional drug delivery.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Hepatic artery infusion and chemoembolization in the management of liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Loco-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Hepatic artery embolization for hepatocellular carcinoma: technique, patient selection, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Transcatheter arterial chemoembolization with paclitaxel-lipiodol solution in rabbit VX2 liver tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

An update on hepatic arterial infusion chemotherapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Surgical therapy for metastatic disease to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Targeted therapy in advanced colorectal cancer: more data, more questions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Transarterial chemoembolization of liver metastases of colorectal carcinoma using degradable starch microspheres (Spherex): personal investigations and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

A new chemoembolization protocol in refractory liver metastasis of colorectal cancer--a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Hepatic artery infusion chemotherapy for metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Intrahepatic arterial infusion of chemotherapy: pharmacologic principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Implanted hepatic arterial infusion pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Radiologic placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Hepatic arterial port systems for treatment of liver metastases: factors affecting patency and adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Systemic therapy for metastatic colorectal cancer: current options, current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Advances in neoadjuvant therapy for colorectal cancer with liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Isolated hepatic perfusion: treating unresectable liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases; a new simplified technique in isolated hepatic perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Increased Expression of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

Treatment of Liver Metastases by Arterial Injection of Adriamycin/Mitomycin C Lipiodol Suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.574125

10.1517/17425247.2011.574125

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference